Astramorph PF and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Astramorph PF and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, Avinza, MS Contin, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Astramorph PF (Injection)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Astramorph PF-Insulin degludec
- Astramorph PF-Insulin Degludec (U-100) Prefilled Pens
- Astramorph PF-Insulin Degludec (U-100) Vials
- Astramorph PF-Insulin Degludec (U-200) Prefilled Pens
- Astramorph PF-Insulin degludec and liraglutide
- Astramorph PF-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Atacand
- Insulin aspart, recombinant Subcutaneous-Atacand HCT
- Insulin aspart, recombinant Subcutaneous-Atarax
- Insulin aspart, recombinant Subcutaneous-Atarax (Hydroxyzine Capsules and Tablets)
- Insulin aspart, recombinant Subcutaneous-Atarax (Hydroxyzine Syrup)
- Insulin aspart, recombinant Subcutaneous-Atasol